Medication information
Prescription

Abacavir/Lamivudine (Kivexa)

Backbone NRTI for HIV

Abacavir/Lamivudine (Kivexa) is an HIV combination tablet, paired with a third drug. Patients are tested for HLA-B*5701 before starting — abacavir hypersensitivity is rare but serious.

How the pharmacy helps

We dispense once daily. Discreet refills and adherence support.

Access framing

Available by prescription only.

Access

Available by prescription only.

Forms and strengths

Medication entries grouped here

Strengths, dosage forms, brands, or package entries may vary. Your prescription label and pharmacist counselling are the instructions to follow.

Brand / GenericStrengthFormDINRecord
Kivexa
Abacavir/Lamivudine
600/300mgTabletActive
COMMON QUESTIONS

Questions
Abacavir/Lamivudine (Kivexa) Questions

Contact Us
Done once before starting. Result stays on file.
Carry the warning card. Stop and seek care for fever, rash, or flu-like symptoms in the first weeks.
Take as soon as you remember within several hours; otherwise skip and resume.

Related pages in HIV Care

Darunavir

Boosted protease inhibitor for HIV

Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy)

Single-tablet daily regimen for HIV treatment

Dolutegravir

HIV integrase inhibitor — used in combination regimens

Have questions about this medication?

Call the pharmacy or bring the medication to the counter. We can help compare labels, dosing schedules, storage needs, and questions to ask your prescriber.

Back to medication information